Device promotion oversight could be placed solely with FTC, advertising group says.
This article was originally published in The Gray Sheet
Executive Summary
DEVICE, DRUG PROMOTIONAL ACTIVITIES REGULATION EXCLUSIVELY BY FTC is proposed by the American Association of Advertising Agencies (AAAA) in its legislative proposal to reform FDA's device and drug marketing and communications regulations. Congress "could grant FTC exclusive jurisdiction to regulate marketing of prescription drugs and devices where the FDA and FTC now have concurrent and overlapping jurisdictions," the association says, as "one way to accomplish both substantive and procedural reform."